Relmada Therapeutics Inc (NASDAQ: RLMD) on Tuesday, soared 7.56% from the previous trading day, before settling in for the closing price of $3.97. Within the past 52 weeks, RLMD’s price has moved between $0.24 and $4.34.
Healthcare Sector giant saw their annual sales surged by 0.68% over the last five years. The company achieved an average annual earnings per share of 37.80%. With a float of $50.90 million, this company’s outstanding shares have now reached $73.33 million.
Relmada Therapeutics Inc (RLMD) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Relmada Therapeutics Inc is 30.59%, while institutional ownership is 14.57%. The most recent insider transaction that took place on Nov 05 ’25, was worth 1,100,000. In this transaction Chief Financial Officer of this company bought 500,000 shares at a rate of $2.20, taking the stock ownership to the 788,335 shares. Before that another transaction happened on Nov 05 ’25, when Company’s CAO and COO bought 136,000 for $2.20, making the entire transaction worth $299,200. This insider now owns 403,931 shares in total.
Relmada Therapeutics Inc (RLMD) Earnings and Forecasts
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.59 earnings per share (EPS) for the period topping the consensus outlook (set at -0.83) by 0.24.
According to the Wall Street analysts, stocks earnings will be around 37.80% per share during the next fiscal year.
Relmada Therapeutics Inc (NASDAQ: RLMD) Trading Performance Indicators
Relmada Therapeutics Inc (RLMD) is currently performing well based on its current performance indicators. A quick ratio of 2.86 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.80, a number that is poised to hit -0.36 in the next quarter
Technical Analysis of Relmada Therapeutics Inc (RLMD)
Analysing the last 5-days average volume posted by the [Relmada Therapeutics Inc, RLMD], we can find that recorded value of 1.43 million was better than the volume posted last year of 1.18 million. As of the previous 9 days, the stock’s Stochastic %D was 85.50%.
During the past 100 days, Relmada Therapeutics Inc’s (RLMD) raw stochastic average was set at 96.88%, which indicates a significant increase from 94.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.48 in the past 14 days, which was higher than the 0.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.29, while its 200-day Moving Average is $0.97. Now, the first resistance to watch is $4.53. This is followed by the second major resistance level at $4.79. The third major resistance level sits at $5.20. If the price goes on to break the first support level at $3.87, it is likely to go to the next support level at $3.46. Should the price break the second support level, the third support level stands at $3.20.
Relmada Therapeutics Inc (NASDAQ: RLMD) Key Stats
Market capitalization of the company is 313.13 million based on 33,192K outstanding shares. Right now, sales total 0 K and income totals -79,980 K. The company made 0 K in profit during its latest quarter, and -10,090 K in sales during its previous quarter.
